Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

CABACabaletta Bio, Inc.

Nasdaq · CIK 0001759138
Filer categoryNon-accelerated filer<br>Smaller reporting company
Entity typeoperating
SIC2836 Biological Products, (No Diagnostic Substances)
FY end1231
XBRL facts218

Identity from submissions API

NameCabaletta Bio, Inc.
CIK0001759138
TickersCABA
ExchangesNasdaq
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company
SIC2836 Biological Products, (No Diagnostic Substances)
EIN000000000
LEI—
Fiscal year end1231
State of incorporationDE DE
Phone(267) 759-3100
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • None listed.
Business address
2929 ARCH STREET
SUITE 600
PHILADELPHIA
PA
19104
PA
Mailing address
2929 ARCH STREET
SUITE 600
PHILADELPHIA
PA
19104
PA

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

454 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-16 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001172661-26-005291 005-91178 261559136 34 9761
2026-11-16 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001193125-26-461980 005-91178 261555301 34 8956
2026-11-12 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001374170-26-000074 005-91178 261543240 34 7570
2026-11-09 8-K 8-K 7.01,8.01,9.01 0001759138-26-000050 001-39103 261533627 34 26267253 1 1
2026-11-06 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001897612-26-000706 005-91178 261530260 34 9485
2026-11-06 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001897612-26-000701 005-91178 261530167 34 7702
2026-11-05 10-Q 10-Q 0001759138-26-000047 001-39103 261524824 34 9035751 1 1
2026-11-05 8-K 8-K 2.02,9.01 0001759138-26-000046 001-39103 261524811 34 336374 1 1
2026-10-30 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0002100119-26-001567 005-91178 261505531 34 7543
2026-10-27 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0002012383-26-003765 005-91178 261491632 34 10901
2026-09-14 8-K 8-K 8.01 0001759138-26-000041 001-39103 261375854 34 154308 1 1
2026-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001172661-26-003687 005-91178 261279654 34 10462
2026-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001897612-26-000608 005-91178 261277504 34 7704
2026-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001193125-26-350333 005-91178 261275991 34 9344
2026-08-13 10-Q 10-Q 0001759138-26-000039 001-39103 261270077 34 9049540 1 1
2026-08-13 8-K 8-K 2.02,9.01 0001759138-26-000038 001-39103 261270073 34 322433 1 1
2026-08-12 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000919574-26-004972 005-91178 261266236 34 13087
2026-08-12 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001374170-26-000058 005-91178 261265231 34 7534
2026-07-31 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0002100119-26-001326 005-91178 261225843 34 7441
2026-07-27 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0002012383-26-002220 005-91178 261206095 34 10843
2026-07-23 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001104659-26-086361 005-91178 261197948 34 15879
2026-06-11 8-K 8-K 5.03,5.07,9.01 0001759138-26-000033 001-39103 261081418 34 233802 1 1
2026-06-10 4 4 0001193125-26-266239 5446
2026-06-10 4 4 0001193125-26-266232 5339
2026-06-10 4 4 0001193125-26-266229 5363
2026-06-10 4 4 0001193125-26-266224 5359
2026-06-10 4 4 0001193125-26-266220 5351
2026-06-05 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001137774-26-000127 005-91178 261068444 34 7274
2026-06-04 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000053417-26-000042 005-91178 261065223 34 6611
2026-06-03 8-K 8-K 7.01,8.01,9.01 0001759138-26-000030 001-39103 261058900 34 28231115 1 1
2026-06-01 DEFA14A DEFA14A 0001193125-26-249726 001-39103 261047168 34 27867
2026-05-15 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001172661-26-002219 005-91178 26985223 34 10417
2026-05-14 10-Q 10-Q 0001759138-26-000026 001-39103 26975804 34 7665742 1 1
2026-05-14 8-K 8-K 2.02,9.01 0001759138-26-000025 001-39103 26975801 34 300392 1 1
2026-05-14 8-K 8-K 7.01,8.01,9.01 0001759138-26-000024 001-39103 26975789 34 28018084 1 1
2026-05-04 8-K 8-K 1.01,2.02,8.01,9.01 0001193125-26-202446 001-39103 26934559 34 8051565 1 1
2026-05-04 424B5 424B5 0001193125-26-202441 333-278126 26934556 33 660983
2026-05-04 8-K 8-K 8.01,9.01 0001193125-26-202389 001-39103 26934488 34 152626 1 1
2026-04-28 ARS ARS 0001193125-26-183571 001-39103 26903161 34 1436538
2026-04-28 DEFA14A DEFA14A 0001193125-26-183564 001-39103 26903155 34 470582
2026-04-28 DEF 14A DEF 14A 0001193125-26-183557 001-39103 26903147 34 3199425 1 1
2026-04-20 8-K 8-K 8.01,9.01 0001759138-26-000016 001-39103 26873334 34 27884519 1 1
2026-04-17 PRE 14A PRE 14A 0001193125-26-160326 001-39103 26869415 34 3180264 1 1
2026-03-23 S-8 S-8 0001759138-26-000013 333-294514 26779914 33 442228 1 1
2026-03-23 10-K 10-K 0001759138-26-000011 001-39103 26779910 34 14952232 1 1
2026-03-23 8-K 8-K 2.02,7.01,9.01 0001759138-26-000010 001-39103 26779905 34 26440930 1 1
2026-03-02 4 4 0001193125-26-086145 5397
2026-03-02 4 4 0001193125-26-086143 5460
2026-03-02 4 4 0001193125-26-086135 5421
2026-03-02 4 4 0001193125-26-086129 5408
2026-03-02 4 4 0001193125-26-086123 5413
2026-03-02 4 4 0001193125-26-086118 5399
2026-02-18 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-26-017121 005-91178 26649855 34 15201
2026-02-17 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001172661-26-001156 005-91178 26642377 34 10742
2026-02-17 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001172661-26-001031 005-91178 26640007 34 10322
2026-02-17 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001897612-26-000278 005-91178 26637802 34 9361
2026-01-21 4 4 0001193125-26-018327 4426
2026-01-21 4 4 0001193125-26-018325 4443
2026-01-21 4 4 0001193125-26-018324 4602
2026-01-21 4 4 0001193125-26-018323 4982
2026-01-21 4 4 0001193125-26-018319 4371
2026-01-21 4 4 0001193125-26-018318 6030
2026-01-21 4 4 0001193125-26-018317 5596
2026-01-21 4 4 0001193125-26-018316 4960
2026-01-12 8-K 8-K 7.01,8.01 0001193125-26-009819 001-39103 26524739 34 25923735 1 1
2025-11-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001172661-25-005189 005-91178 251489021 34 10739
2025-11-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-25-112515 005-91178 251486127 34 18485
2025-11-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001172661-25-004955 005-91178 251483879 34 11551
2025-11-10 10-Q 10-Q 0001193125-25-273280 001-39103 251464370 34 9273000 1 1
2025-11-10 8-K 8-K 2.02,9.01 0001193125-25-273272 001-39103 251464361 34 324795 1 1
2025-11-07 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001137774-25-000181 005-91178 251461857 34 7305
2025-11-07 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001897612-25-000509 005-91178 251461663 34 9368
2025-11-07 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001897612-25-000506 005-91178 251461653 34 7580
2025-11-05 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000053417-25-000098 005-91178 251453163 34 6519
2025-10-29 8-K 8-K 8.01,9.01 0001193125-25-254610 001-39103 251426774 34 27607042 1 1
2025-10-27 8-K 8-K 7.01,8.01,9.01 0001193125-25-250676 001-39103 251417430 34 26146561 1 1
2025-10-15 4 4 0001193125-25-240356 5715
2025-10-15 3 3 0001193125-25-240316 16566
2025-10-09 8-K 8-K 7.01,8.01,9.01 0001193125-25-235533 001-39103 251384065 34 26058086 1 1
2025-09-03 8-K 8-K 7.01,9.01 0001759138-25-000007 001-39103 251287660 34 21806851 1 1
2025-08-15 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-002642 333-289339 251226184 33 1769
2025-08-14 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001172661-25-003544 005-91178 251221246 34 11115
2025-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000950170-25-108821 005-91178 251218358 34 9244
2025-08-14 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001172661-25-003433 005-91178 251217841 34 10775
2025-08-13 CORRESP filename1.htm 0001193125-25-179840 6681
2025-08-13 UPLOAD filename1.pdf 0000000000-25-008485 333-289339 40137
2025-08-12 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000902664-25-003505 005-91178 251204572 34 13122
2025-08-11 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001470831-25-000124 005-91178 251202399 34 6989
2025-08-07 S-3 S-3 0001193125-25-175003 333-289339 251191779 33 1664673 1 1
2025-08-07 10-Q 10-Q 0000950170-25-104573 001-39103 251191655 34 9661000 1 1
2025-08-07 8-K 8-K 2.02,9.01 0000950170-25-104570 001-39103 251191643 34 323827 1 1
2025-08-06 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000053417-25-000082 005-91178 251189787 34 6519
2025-08-06 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001137774-25-000122 005-91178 251188932 34 7301
2025-07-29 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000932471-25-000810 005-91178 251159092 34 6272
2025-07-16 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0002052113-25-002491 005-91178 251128407 34 10718
2025-06-20 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-25-061235 005-91178 251062390 34 27915
2025-06-12 8-K 8-K 1.01,8.01,9.01 0001193125-25-139517 001-39103 251041600 34 683174 1 1
2025-06-12 424B5 424B5 0001193125-25-139512 333-278126 251041591 33 713733
2025-06-11 424B5 424B5 0001193125-25-138755 333-278126 251038744 33 716715
2025-06-11 8-K 8-K 1.02,7.01,8.01,9.01 0001193125-25-138737 001-39103 251038723 34 5784931 1 1
2025-06-10 8-K 8-K 5.03,5.07,9.01 0001193125-25-137954 001-39103 251035283 34 175628 1 1
2025-06-09 4 4 0000950170-25-084022 5202
2025-06-09 4 4 0000950170-25-084019 5214
2025-06-09 4 4 0000950170-25-084017 5222
2025-06-09 4 4 0000950170-25-084015 5309
2025-06-09 4 4 0000950170-25-084014 5226
2025-05-19 4 4 0000950170-25-074832 17189
2025-05-19 4 4 0000950170-25-074826 29701
2025-05-19 4 4 0000950170-25-074825 21377
2025-05-19 4 4 0000950170-25-074824 21332
2025-05-19 4 4 0000950170-25-074823 13150
2025-05-19 4 4 0000950170-25-074818 33809
2025-05-19 4 4 0000950170-25-074817 21308
2025-05-19 4 4 0000950170-25-074816 29664
2025-05-19 4 4 0000950170-25-074811 25525
2025-05-19 4 4 0000950170-25-074810 21304
2025-05-19 4 4 0000950170-25-074808 33790
2025-05-19 8-K 8-K 5.02 0000950170-25-074589 001-39103 25965158 34 152372 1 1
2025-05-15 10-Q 10-Q 0000950170-25-071971 001-39103 25948662 34 7376449 1 1
2025-05-15 8-K 8-K 2.02,7.01,9.01 0000950170-25-071966 001-39103 25948640 34 226504 1 1
2025-05-13 ARS ARS 0001193125-25-118332 001-39103 25937232 34 1335195
2025-05-13 DEF 14A DEF 14A 0001193125-25-118330 001-39103 25937224 34 3370716 1 1
2025-04-30 PRE 14A PRE 14A 0001193125-25-105790 001-39103 25891074 34 3383837 1 1
2025-03-31 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-000868 333-278126 25796301 33 1781
2025-03-31 S-8 S-8 0000950170-25-047233 333-286246 25789077 33 174220
2025-03-31 POS AM POS AM 0001193125-25-067883 333-278126 25789046 33 694157
2025-03-31 10-K 10-K 0000950170-25-047201 001-39103 25788880 34 14109495 1 1
2025-03-31 POSASR POSASR 0001193125-25-067749 333-278126 25788828 33 650153
2025-03-31 8-K 8-K 2.02,9.01 0000950170-25-047196 001-39103 25788810 34 308004 1 1
2025-03-04 4 4 0000950170-25-032326 5425
2025-03-04 4 4 0000950170-25-032314 5406
2025-03-04 4 4 0000950170-25-032303 5385
2025-03-04 4 4 0000950170-25-032299 5401
2025-03-04 4 4 0000950170-25-032295 5412
2025-03-04 4 4 0000950170-25-032271 5417
2025-02-18 8-K/A 8-K/A 7.01,8.01,9.01 0001193125-25-028420 001-39103 25633993 34 191313 1 1
2025-02-18 8-K 8-K 7.01,8.01,9.01 0001193125-25-028143 001-39103 25632715 34 4076065 1 1
2025-02-05 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0002012383-25-001192 005-91178 25592178 34 11777
2025-01-13 8-K 8-K 2.02,7.01,8.01,9.01 0001193125-25-005016 001-39103 25524924 34 6552812 1 1
2024-12-06 SC 13G/A CABALETTA BIO, INC. 0001193125-24-272447 005-91178 241532300 34 47868
2024-12-05 SC 13G/A caba2.htm 0001137774-24-000286 005-91178 241529726 34 9398
2024-12-05 SC 13G/A CABA 11302024 13G/A 0000053417-24-000112 005-91178 241528954 34 8794
2024-11-18 8-K 8-K 7.01,8.01,9.01 0001193125-24-260425 001-39103 241469745 34 18133248 1 1
2024-11-14 SC 13G/A SC 13G/A 0001104659-24-119311 005-91178 241464751 34 165358
2024-11-14 SC 13G/A CABALETTA BIO, INC. 0001193125-24-258531 005-91178 241461635 34 47119
2024-11-14 SC 13G caba13gsep24.txt 0001897612-24-001980 005-91178 34 6508
2024-11-14 10-Q 10-Q 0000950170-24-126733 001-39103 241457155 34 8410896 1 1
2024-11-14 8-K 8-K 2.02,9.01 0000950170-24-126731 001-39103 241457141 34 290277 1 1
2024-11-12 SC 13G/A UnitedStates_13G__CabalettaB.txt 0000932471-24-000852 005-91178 241446482 34 6567
2024-11-12 SC 13G/A CABALETTA BIO, INC. 0000902664-24-006409 005-91178 241444233 34 72354
2024-11-04 SC 13G/A UnitedStates_13G__CabalettaB.txt 0000932471-24-000312 005-91178 241421802 34 5632
2024-11-04 SC 13G/A UnitedStates_13G__CabalettaB.txt 0000932471-24-000389 005-91178 241421595 34 5632
2024-11-04 SC 13G/A UnitedStates_13G__CabalettaB.txt 0000932471-24-000388 005-91178 241421593 34 5632
2024-10-17 SC 13G/A Cabaletta_Bio_Inc.htm 0000093751-24-000814 005-91178 241376658 34 55858
2024-10-07 8-K 8-K 7.01,8.01,9.01 0001193125-24-233294 001-39103 241356037 34 3500802 1 1
2024-09-30 8-K 8-K 1.01 0000950170-24-110389 001-39103 241339864 34 163285 1 1
2024-08-22 SC 13G SC 13G 0001193125-24-205483 005-91178 241233070 34 51550
2024-08-08 10-Q 10-Q 0000950170-24-093325 001-39103 241186052 34 7811142 1 1
2024-08-08 8-K 8-K 2.02,7.01,9.01 0001193125-24-196467 001-39103 241185990 34 3680685 1 1
2024-06-14 8-K 8-K 7.01,8.01,9.01 0001193125-24-161089 001-39103 241043017 34 9458205 1 1
2024-06-10 SC 13G CABALETTA.HTM 0001137774-24-000084 005-91178 241033571 34 9442
2024-06-06 SC 13G 13G MONTHLY FILING - CABA 0000053417-24-000060 005-91178 241024450 34 8785
2024-06-04 4 4 0000950170-24-068996 5233
2024-06-04 4 4 0000950170-24-068993 5213
2024-06-04 4 4 0000950170-24-068992 5237
2024-06-04 4 4 0000950170-24-068984 5225
2024-06-04 4 4 0000950170-24-068982 5320
2024-06-04 8-K 8-K 5.07 0001193125-24-154309 001-39103 241018684 34 155541 1 1
2024-05-15 10-Q 10-Q 0000950170-24-060045 001-39103 24947211 34 7020152 1 1
2024-05-15 8-K 8-K 2.02,7.01,9.01 0001193125-24-138874 001-39103 24947104 34 10506558 1 1
2024-04-23 ARS ARS 0001193125-24-105900 001-39103 24862680 34 3608511
2024-04-23 DEFA14A DEFA14A 0001193125-24-105890 001-39103 24862673 34 162363
2024-04-23 DEF 14A DEF 14A 0001193125-24-105870 001-39103 24862666 34 624801
2024-03-21 S-3ASR S-3ASR 0001193125-24-073325 333-278126 24769533 33 1435581
2024-03-21 S-8 S-8 0001193125-24-073318 333-278124 24769496 33 55259
2024-03-21 10-K 10-K 0000950170-24-034422 001-39103 24769419 34 10368131 1 1
2024-03-21 8-K 8-K 2.02,9.01 0001193125-24-073294 001-39103 24769408 34 224506 1 1
2024-03-20 8-K 8-K 7.01,9.01 0001193125-24-072048 001-39103 24766272 34 178019 1 1
2024-03-04 4 4 0000950170-24-025039 5389
2024-03-04 4 4 0000950170-24-025027 5416
2024-03-04 4 4 0000950170-24-025012 5421
2024-03-04 4 4 0000950170-24-025004 5410
2024-03-04 4 4 0000950170-24-025002 5405
2024-03-04 4 4 0000950170-24-024978 5470
2024-02-14 SC 13G/A SC 13G/A 0001104659-24-024234 005-91178 24641713 34 152162
2024-02-14 SC 13G/A SC 13G/A 0001104659-24-023726 005-91178 24638755 34 98645
2024-02-14 SC 13G/A CABALETTA BIO, INC. 0001193125-24-036204 005-91178 24638212 34 50361
2024-02-14 SC 13G/A formsc13ga.htm 0001493152-24-006619 005-91178 24637779 34 91553
2024-02-14 SC 13G/A AMENDMENT NO. 2 0000929638-24-000640 005-91178 24636478 34 123045
2024-02-14 SC 13G/A CABALETTA BIO, INC. 0000902664-24-001609 005-91178 24633030 34 67267
2024-02-13 SC 13G/A SC 13G/A 0001193125-24-034084 005-91178 24630862 34 49537
2024-02-13 SC 13G/A SC 13G/A 0001193125-24-033809 005-91178 24626613 34 47182
2024-02-12 SC 13G/A e619242_sc13ga-cb.htm 0001193805-24-000180 005-91178 24621415 34 130555
2024-02-07 SC 13G/A CABALETTA BIO, INC. 0000902664-24-001128 005-91178 24602104 34 98734
2024-02-01 8-K 8-K 7.01,8.01,9.01 0001193125-24-021894 001-39103 24587472 34 191758 1 1
2024-01-24 SC 13G Cabaletta_Bio_Inc.txt 0000093751-24-000134 005-91178 24554728 34 8476
2024-01-19 4 4 0000950170-24-005888 10849
2024-01-08 SC 13G us12674w1099_010824.txt 0001086364-24-000182 005-91178 24520611 34 13495
2024-01-08 8-K 8-K 2.02,7.01,8.01,9.01 0001193125-24-003872 001-39103 24518314 34 9330373 1 1
2023-12-19 4 4 0000950170-23-071689 10850
2023-11-21 4 4 0000950170-23-065521 10768
2023-11-20 144 xsl144X01/primary_doc.xml 0001950047-23-005215 001-39103 231422963 33 6900
2023-11-09 10-Q 10-Q 0000950170-23-061528 001-39103 231390057 34 8878895 1 1
2023-11-09 8-K 8-K 2.02,7.01,9.01 0001193125-23-274053 001-39103 231390032 34 4887705 1 1
2023-11-06 8-K 8-K 7.01,8.01,9.01 0001193125-23-270840 001-39103 231378081 34 190113 1 1
2023-10-19 4 4 0000950170-23-054234 10766
2023-10-19 144 xsl144X01/primary_doc.xml 0001950047-23-004577 001-39103 231334772 33 6175
2023-10-02 8-K 8-K 7.01,8.01,9.01 0001193125-23-248186 001-39103 231297742 34 14882204 1 1
2023-09-20 4 4 0000950170-23-049005 10764
2023-09-19 144 xsl144X01/primary_doc.xml 0001950047-23-004172 001-39103 231264116 33 6900
2023-09-05 8-K 8-K 7.01,9.01 0001193125-23-228144 001-39103 231234244 34 4112555 1 1
2023-08-22 4 4 0000950170-23-043920 10775
2023-08-22 8-K 8-K 7.01,8.01,9.01 0001193125-23-217481 001-39103 231191008 34 180373 1 1
2023-08-21 144 xsl144X01/primary_doc.xml 0001950047-23-003296 001-39103 231189343 33 6173
2023-08-10 S-8 S-8 0001193125-23-208133 333-273863 231157231 33 57499
2023-08-10 10-Q 10-Q 0000950170-23-040966 001-39103 231157225 34 9468660 1 1
2023-08-10 8-K 8-K 2.02,9.01 0001193125-23-208095 001-39103 231157170 34 216525 1 1
2023-07-24 4 4 0000950170-23-033944 5316
2023-07-24 3 3 0000950170-23-033943 6681
2023-07-24 8-K 8-K 5.02,7.01,8.01,9.01 0001193125-23-191895 001-39103 231103783 34 4136219 1 1
2023-07-19 4 FORM 4 SUBMISSION 0000899243-23-017452 11442
2023-07-19 144 xsl144X01/primary_doc.xml 0001950047-23-002434 001-39103 231096828 33 6173
2023-06-21 4 FORM 4 SUBMISSION 0000899243-23-016147 9369
2023-06-20 144 xsl144X01/primary_doc.xml 0001950047-23-001769 001-39103 231025434 33 5448
2023-06-20 144 xsl144X01/primary_doc.xml 0001950047-23-001767 001-39103 231025422 33 5448
2023-06-02 4 FORM 4 SUBMISSION 0000899243-23-014333 5358
2023-06-02 4 FORM 4 SUBMISSION 0000899243-23-014332 5378
2023-06-02 4 FORM 4 SUBMISSION 0000899243-23-014331 5382
2023-06-02 4 FORM 4 SUBMISSION 0000899243-23-014330 5370
2023-06-01 SC 13G SC 13G 0001193125-23-159011 005-91178 23985354 34 49921
2023-06-01 8-K 8-K 5.02,5.07,9.01 0001193125-23-158936 001-39103 23984685 34 167927 1 1
2023-05-26 SC 13G e618673_sc13g-cb.htm 0001193805-23-000796 005-91178 23967735 34 130171
2023-05-22 8-K 8-K 8.01,9.01 0001193125-23-150530 001-39103 23945039 34 172382 1 1
2023-05-19 4 FORM 4 SUBMISSION 0000899243-23-013455 9368
2023-05-19 144 xsl144X01/primary_doc.xml 0001950047-23-000807 001-39103 23940556 33 4722
2023-05-18 8-K 8-K 1.01,8.01,9.01 0001193125-23-148212 001-39103 23936591 34 510118 1 1
2023-05-18 424B5 424B5 0001193125-23-148191 333-270599 23936494 33 634918
2023-05-18 424B5 424B5 0001193125-23-147294 333-270599 23933554 33 640818
2023-05-16 8-K 8-K 7.01,8.01,9.01 0001193125-23-146067 001-39103 23927367 34 14821507 1 1
2023-05-16 8-K 8-K 7.01,9.01 0001193125-23-145622 001-39103 23925550 34 179178 1 1
2023-05-11 10-Q 10-Q 0000950170-23-020849 001-39103 23908872 34 7929927 1 1
2023-05-11 8-K 8-K 2.02,9.01 0001193125-23-141371 001-39103 23908760 34 207047 1 1
2023-05-02 8-K 8-K 7.01,8.01,9.01 0001193125-23-132565 001-39103 23879793 34 196065 1 1
2023-05-01 8-K 8-K 7.01,8.01,9.01 0001193125-23-128724 001-39103 23869986 34 13662224 1 1
2023-04-26 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2023-04-26 16:01:00 9999999995-23-001056 333-270599 23851551 33 1726
2023-04-24 CORRESP filename1.htm 0001193125-23-112827 6421
2023-04-21 ARS ARS 0001193125-23-109213 001-39103 23834496 34 7619008
2023-04-21 DEFA14A DEFA14A 0001193125-23-109207 001-39103 23834492 34 36345
2023-04-21 DEF 14A DEF 14A 0001193125-23-109203 001-39103 23834488 34 573241
2023-03-31 8-K 8-K 7.01,8.01,9.01 0001193125-23-086713 001-39103 23783188 34 13434602 1 1
2023-03-22 UPLOAD filename1.pdf 0000000000-23-002866 40309
2023-03-16 S-3 S-3 0001193125-23-072030 333-270599 23737257 33 1393481
2023-03-16 S-8 S-8 0001193125-23-071978 333-270595 23737153 33 53610
2023-03-16 10-K 10-K 0000950170-23-008298 001-39103 23737124 34 11692324 1 1
2023-03-16 8-K 8-K 2.02,7.01,9.01 0001193125-23-071942 001-39103 23737110 34 12228458 1 1
2023-03-06 8-K 8-K 8.01,9.01 0001193125-23-060668 001-39103 23707513 34 12151007 1 1
2023-02-14 SC 13G/A CABALETTA BIO, INC. 0000902664-23-001805 005-91178 23629074 34 66353
2023-02-14 SC 13G SC 13G 0001104659-23-021472 005-91178 23628443 34 120345
2023-02-14 SC 13G/A sc13ga.htm 0000929638-23-000562 005-91178 23627743 34 123688
2023-02-14 SC 13G/A SC 13G/A 0001104659-23-020779 005-91178 23622736 34 137802
2023-02-14 SC 13G/A SC 13G/A 0001019056-23-000134 005-91178 23622362 34 155645
2023-02-14 SC 13G/A SC 13G/A 0001193125-23-036893 005-91178 23621806 34 47195
2023-02-10 SC 13G CABALETTA BIO, INC. 0001193125-23-032530 005-91178 23611730 34 52392
2023-02-09 SC 13G/A CABALETTA BIO, INC. 0000902664-23-001367 005-91178 23605072 34 102381
2023-01-27 4 FORM 4 SUBMISSION 0000899243-23-002914 5539
2023-01-27 4 FORM 4 SUBMISSION 0000899243-23-002913 5506
2023-01-27 4 FORM 4 SUBMISSION 0000899243-23-002912 5522
2023-01-27 4 FORM 4 SUBMISSION 0000899243-23-002910 5562
2023-01-27 4 FORM 4 SUBMISSION 0000899243-23-002908 5533
2023-01-27 4 FORM 4 SUBMISSION 0000899243-23-002907 5527
2023-01-13 SC 13G formsc13g.htm 0001493152-23-001414 005-91178 23528760 34 97696
2023-01-09 8-K 8-K 7.01,9.01 0001193125-23-004113 001-39103 23516503 34 12034800 1 1
2022-12-23 SC 13G SC 13G 0001104659-22-129901 005-91178 221485543 34 231313
2022-12-12 8-K 8-K 1.01,8.01,9.01 0001193125-22-302822 001-39103 221457689 34 646844 1 1
2022-12-08 8-K 8-K 8.01,9.01 0001193125-22-301060 001-39103 221452892 34 13157161 1 1
2022-12-08 424B5 424B5 0001193125-22-300489 333-250006 221451387 33 586324
2022-12-08 FWP FWP 0001193125-22-300485 333-250006 221451382 34 64886
2022-11-10 10-Q 10-Q 0000950170-22-024168 001-39103 221374982 34 9813906 1 1
2022-11-10 8-K 8-K 2.02,7.01,9.01 0001193125-22-281920 001-39103 221374897 34 13230386 1 1
2022-11-07 SC 13G SC 13G 0001193125-22-279136 005-91178 221365919 34 47054
2022-10-31 SC 13G CABALETTA BIO, INC 0000902664-22-004692 005-91178 221346552 34 67641
2022-10-31 SC 13G sc13g.htm 0000929638-22-001618 005-91178 221345949 34 126443
2022-10-19 4 FORM 4 SUBMISSION 0000899243-22-033850 5619
2022-10-18 4 FORM 4 SUBMISSION 0000899243-22-033783 4518
2022-10-18 4 FORM 4 SUBMISSION 0000899243-22-033782 5098
2022-10-18 4 FORM 4 SUBMISSION 0000899243-22-033781 6914
2022-10-18 4 FORM 4 SUBMISSION 0000899243-22-033780 5134
2022-10-18 4 FORM 4 SUBMISSION 0000899243-22-033779 6145
2022-10-11 8-K 8-K 1.01,7.01,8.01,9.01 0001193125-22-260195 001-39103 221302309 34 13196022 1 1
2022-09-12 8-K 8-K 7.01,8.01,9.01 0001193125-22-242340 001-39103 221237314 34 16397990 1 1
2022-08-29 8-K 8-K 8.01,9.01 0001193125-22-232575 001-39103 221210387 34 178531 1 1
2022-08-22 SC 13G SC 13G 0001019056-22-000570 005-91178 221182308 34 154131
2022-08-11 10-Q 10-Q 0000950170-22-016650 001-39103 221153727 34 8286367 1 1
2022-08-11 8-K 8-K 2.02,7.01,9.01 0001193125-22-217960 001-39103 221153661 34 14635399 1 1
2022-08-03 SC 13D/A SC 13D/A 0001104659-22-085691 005-91178 221133473 34 163686
2022-06-03 4 FORM 4 SUBMISSION 0000899243-22-020999 9026
2022-06-03 4 FORM 4 SUBMISSION 0000899243-22-020998 9014
2022-06-03 4 FORM 4 SUBMISSION 0000899243-22-020997 9057
2022-06-03 4 FORM 4 SUBMISSION 0000899243-22-020995 9048
2022-06-02 8-K 8-K 5.07 0001193125-22-165785 001-39103 22989284 34 156508 1 1
2022-05-18 8-K 8-K 7.01,8.01,9.01 0001193125-22-153543 001-39103 22937023 34 14687237 1 1
2022-05-12 10-Q 10-Q 0001564590-22-019677 001-39103 22915754 34 6902052 1 1
2022-05-12 8-K 8-K 2.02,9.01 0001193125-22-148046 001-39103 22915665 34 206519 1 1
2022-05-02 8-K 8-K 7.01,9.01 0001193125-22-136873 001-39103 22882593 34 194518 1 1
2022-04-21 DEFA14A DEFA14A 0001193125-22-112143 001-39103 22839711 34 354738
2022-04-21 DEF 14A DEF 14A 0001193125-22-112140 001-39103 22839705 34 725675
2022-03-17 S-8 S-8 0001193125-22-078283 333-263637 22748422 33 50550
2022-03-17 10-K 10-K 0001564590-22-010726 001-39103 22746853 34 16778215 1 1
2022-03-17 8-K 8-K 2.02,7.01,9.01 0001193125-22-077793 001-39103 22746712 34 14151256 1 1
2022-03-14 8-K/A 8-K/A 7.01,9.01 0001193125-22-074084 001-39103 22735116 34 13930051 1 1
2022-03-03 8-K 8-K 7.01,9.01 0001193125-22-063683 001-39103 22706806 34 13939286 1 1
2022-03-01 8-K 8-K 8.01 0001193125-22-059886 001-39103 22694049 34 154243 1 1
2022-02-14 SC 13G/A SC 13G/A 0001104659-22-023131 005-91178 22634473 34 68366
2022-02-14 SC 13G/A SC 13G/A 0001193125-22-041953 005-91178 22633400 34 85400
2022-02-14 SC 13G/A sc13g.htm 0000929638-22-000486 005-91178 22630259 34 126292
2022-02-14 SC 13G/A CABALETTA BIO, INC. 0001104659-22-021311 005-91178 22624827 34 139944
2022-02-10 SC 13G/A CABALETTA BIO, INC. 0000902664-22-001345 005-91178 22611410 34 105222
2022-02-02 4 FORM 4 SUBMISSION 0000899243-22-004158 8240
2022-01-19 4 FORM 4 SUBMISSION 0000899243-22-002517 9184
2022-01-19 4 FORM 4 SUBMISSION 0000899243-22-002516 5502
2022-01-19 4 FORM 4 SUBMISSION 0000899243-22-002514 5521
2022-01-19 4 FORM 4 SUBMISSION 0000899243-22-002510 9213
2022-01-19 4 FORM 4 SUBMISSION 0000899243-22-002509 9206
2022-01-19 4 FORM 4 SUBMISSION 0000899243-22-002508 9243
2022-01-13 3 FORM 3 SUBMISSION 0000899243-22-001911 10546
2022-01-10 8-K 8-K 7.01,9.01 0001193125-22-005100 001-39103 22519730 34 13219807 1 1
2021-12-14 8-K 8-K 7.01,8.01,9.01 0001193125-21-356168 001-39103 211489670 34 19648842 1 1
2021-11-03 4 FORM 4 SUBMISSION 0001209191-21-062716 16724
2021-11-03 SC 13D/A SC 13D/A 0001104659-21-133670 005-91178 211375947 34 147618
2021-11-01 SC 13G CABALETTA BIO, INC. 0001104659-21-132336 005-91178 211367120 34 144423
2021-11-01 10-Q 10-Q 0001564590-21-053043 001-39103 211365315 34 8596047 1 1
2021-11-01 8-K 8-K 2.02,7.01,8.01,9.01 0001193125-21-314433 001-39103 211365288 34 19419476 1 1
2021-09-09 4 FORM 4 SUBMISSION 0001209191-21-055343 15766
2021-09-09 SC 13D/A SC 13D/A 0001104659-21-114209 005-91178 211244755 34 197122
2021-09-03 4 FORM 4 SUBMISSION 0000899243-21-035110 5403
2021-09-03 3 FORM 3 SUBMISSION 0000899243-21-035102 6595
2021-08-18 8-K 8-K 7.01,8.01,9.01 0001193125-21-249668 001-39103 211184996 34 19065381 1 1
2021-08-05 10-Q 10-Q 0001564590-21-041196 001-39103 211146386 34 8322857 1 1
2021-08-05 8-K 8-K 2.02,7.01,9.01 0001193125-21-237002 001-39103 211146356 34 19416494
2021-06-28 4 FORM 4 SUBMISSION 0000899243-21-026198 5419
2021-06-28 4/A FORM 4/A SUBMISSION 0000899243-21-026199 5748
2021-06-28 3 FORM 3 SUBMISSION 0000899243-21-026172 6521
2021-06-28 8-K 8-K 5.02,9.01 0001193125-21-201119 001-39103 211050026 34 37625
2021-06-03 4 FORM 4 SUBMISSION 0000899243-21-021795 5321
2021-06-03 4 FORM 4 SUBMISSION 0000899243-21-021792 5350
2021-06-03 4 FORM 4 SUBMISSION 0000899243-21-021793 5341
2021-06-03 4 FORM 4 SUBMISSION 0000899243-21-021791 5341
2021-06-03 8-K 8-K 5.07,7.01,9.01 0001193125-21-180577 001-39103 21991171 34 19716710
2021-05-03 10-Q 10-Q 0001564590-21-022689 001-39103 21881318 34 6162687 1
2021-05-03 8-K 8-K 2.02,7.01,8.01,9.01 0001193125-21-146616 001-39103 21881295 34 19890596
2021-04-21 DEFA14A DEFA14A 0001193125-21-124712 001-39103 21841689 34 62910
2021-04-21 DEF 14A DEF 14A 0001193125-21-124695 001-39103 21841652 34 414372
2021-04-06 8-K 8-K 7.01,9.01 0001193125-21-106915 001-39103 21808068 34 14365853
2021-03-16 S-8 S-8 0001193125-21-082805 333-254342 21745816 33 51473
2021-03-16 10-K 10-K 0001564590-21-013329 001-39103 21743703 34 10921720 1
2021-03-16 8-K 8-K 2.02,9.01 0001193125-21-082134 001-39103 21743642 34 71810
2021-03-02 4 FORM 4 SUBMISSION 0000899243-21-009238 5403
2021-03-02 4 FORM 4 SUBMISSION 0000899243-21-009237 5381
2021-03-02 4 FORM 4 SUBMISSION 0000899243-21-009236 5387
2021-03-02 4 FORM 4 SUBMISSION 0000899243-21-009235 5404
2021-03-02 4 FORM 4 SUBMISSION 0000899243-21-009234 5416
2021-02-16 SC 13G/A SC 13G/A 0001193125-21-045272 005-91178 21641170 34 87480
2021-02-16 SC 13G SCHEDULE 13G 0001104659-21-023925 005-91178 21638173 34 74806
2021-02-16 SC 13G/A sc13g.htm 0000929638-21-000374 005-91178 21636893 34 125859
2021-02-12 SC 13G/A e620278_sc13ga-cabaletta.htm 0001193805-21-000205 005-91178 21624817 34 142147
2021-02-11 SC 13G/A CABALETTA BIO, INC. 0000902664-21-001140 005-91178 21616796 34 105953
2021-01-12 4 FORM 4 SUBMISSION 0001209191-21-003268 20715
2021-01-12 SC 13D/A SC 13D/A 0001104659-21-003503 005-91178 21524107 34 221006
2020-12-14 4 FORM 4 SUBMISSION 0001209191-20-063298 16985
2020-12-14 SC 13D/A SC 13D/A 0001104659-20-135319 005-91178 201387049 34 209968
2020-12-11 424B5 424B5 0001193125-20-315931 333-250006 201383871 33 280794
2020-12-09 4 FORM 4 SUBMISSION 0000899243-20-033173 7315
2020-12-08 8-K 8-K 8.01 0001193125-20-312789 001-39103 201375767 34 21740
2020-11-18 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2020-11-18 16:01:00 9999999995-20-003226 333-250006 201326992 33 1727
2020-11-16 CORRESP filename1.htm 0001193125-20-294729 7039
2020-11-16 UPLOAD filename1.pdf 0000000000-20-010939 40122
2020-11-10 S-3 S-3 0001193125-20-290208 333-250006 201301592 33 1410639
2020-11-10 10-Q 10-Q 0001564590-20-052757 001-39103 201299732 34 7732654 1
2020-11-10 8-K 8-K 2.02,9.01 0001193125-20-289674 001-39103 201299691 34 68030
2020-09-16 4 FORM 4 SUBMISSION 0000899243-20-025326 5400
2020-08-06 10-Q 10-Q 0001564590-20-037278 001-39103 201079939 34 7497703 1
2020-08-06 8-K 8-K 2.02,9.01 0001193125-20-211336 001-39103 201079844 34 62853
2020-07-21 SC 13G CABALETTA BIO, INC. 0000902664-20-002724 005-91178 201038109 34 113747
2020-06-03 8-K 8-K 5.07,7.01,9.01 0001193125-20-159049 001-39103 20938875 34 13258630
2020-05-28 8-K 8-K 1.01,9.01 0001193125-20-153792 001-39103 20917236 34 118976
2020-05-12 10-Q 10-Q 0001564590-20-024508 001-39103 20867442 34 5762386 1
2020-05-12 8-K 8-K 2.02,9.01 0001193125-20-139782 001-39103 20867031 34 62788
2020-05-06 8-K 8-K 8.01 0001193125-20-134391 001-39103 20851223 34 20365
2020-04-23 DEF 14A DEF 14A 0001193125-20-115863 001-39103 20809160 34 535140
2020-03-30 S-8 S-8 0001193125-20-091086 333-237484 20758154 33 48961
2020-03-30 10-K 10-K 0001564590-20-013929 001-39103 20754707 34 8943004 1
2020-03-30 8-K 8-K 2.02,9.01 0001193125-20-090013 001-39103 20754030 34 78354
2020-03-03 4 FORM 4 SUBMISSION 0000899243-20-006867 5387
2020-03-03 4 FORM 4 SUBMISSION 0000899243-20-006865 5401
2020-03-03 4 FORM 4 SUBMISSION 0000899243-20-006864 5378
2020-02-20 8-K 8-K 7.01,9.01 0001193125-20-042689 001-39103 20632567 34 22166742
2020-02-14 SC 13G/A SC 13G/A 0001193125-20-038349 005-91178 20620606 34 112201
2020-02-14 SC 13G/A sc13g.htm 0000929638-20-000331 005-91178 20619457 34 125859
2020-02-13 5 FORM 5 SUBMISSION 0000899243-20-004511 7775
2020-02-13 4 FORM 4 SUBMISSION 0000899243-20-004509 5422

Latest XBRL company facts

One latest value per concept from companyfacts (218 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 215.72M 2026-10-30 2026 Q3 10-Q 2026-11-05 0001759138-26-000047
dei EntityPublicFloat Entity Public Float USD 137.00M 2025-06-30 2025 FY 10-K 2026-03-23 0001759138-26-000011
ecd NonPeoNeoAvgCompActuallyPaidAmt NonPeoNeoAvgCompActuallyPaidAmt USD 838,741 2025-01-01 2025-12-31 DEF 14A 2026-04-28 0001193125-26-183557
ecd NonPeoNeoAvgTotalCompAmt NonPeoNeoAvgTotalCompAmt USD 973,267 2025-01-01 2025-12-31 DEF 14A 2026-04-28 0001193125-26-183557
ecd PeoActuallyPaidCompAmt PeoActuallyPaidCompAmt USD 1.65M 2025-01-01 2025-12-31 DEF 14A 2026-04-28 0001193125-26-183557
ecd PeoTotalCompAmt PeoTotalCompAmt USD 1.94M 2025-01-01 2025-12-31 DEF 14A 2026-04-28 0001193125-26-183557
ecd TotalShareholderRtnAmt TotalShareholderRtnAmt USD 23.68 2025-01-01 2025-12-31 DEF 14A 2026-04-28 0001193125-26-183557
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 9.04M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001759138-26-000047
us-gaap AccretionAmortizationOfDiscountsAndPremiumsInvestments Accretion (Amortization) of Discounts and Premiums, Investments USD 368,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001759138-26-000047
us-gaap AccretionExpense Accretion Expense USD 312,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001759138-26-000047
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 7.15M 2025-12-31 2025 FY 10-K 2026-03-23 0001759138-26-000011
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD 0 2026-09-30 2026 Q3 10-Q 2026-11-05 0001759138-26-000047
us-gaap AdditionalPaidInCapitalCommonStock Additional Paid in Capital, Common Stock USD 948.46M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001759138-26-000047
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 5.26M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001759138-26-000047
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 3.02M 2025-05-19 2026 Q3 10-Q 2026-11-05 0001759138-26-000047
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 18.53M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001759138-26-000047
us-gaap Assets Assets USD 336.49M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001759138-26-000047
us-gaap AssetsCurrent Assets, Current USD 309.85M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001759138-26-000047
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax USD 25,000 2025-12-31 2026 Q3 10-Q 2026-11-05 0001759138-26-000047
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax USD 3,000 2025-09-30 2025 Q3 10-Q 2025-11-10 0001193125-25-273280
us-gaap AvailableForSaleDebtSecuritiesAmortizedCostBasis Debt Securities, Available-for-sale, Amortized Cost USD 133.57M 2025-12-31 2026 Q3 10-Q 2026-11-05 0001759138-26-000047
us-gaap AvailableForSaleEquitySecuritiesGrossUnrealizedGain Available-for-sale Equity Securities, Gross Unrealized Gain USD 11,000 2020-04-01 2020-06-30 2020 Q2 10-Q 2020-08-06 0001564590-20-037278
us-gaap AvailableForSaleSecuritiesDebtSecurities Debt Securities, Available-for-sale USD 133.60M 2025-12-31 2026 Q3 10-Q 2026-11-05 0001759138-26-000047
us-gaap CapitalExpendituresIncurredButNotYetPaid Capital Expenditures Incurred but Not yet Paid USD 265,000 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-13 0001759138-26-000039
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 299.38M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001759138-26-000047
us-gaap CashCashEquivalentsAndShortTermInvestments Cash, Cash Equivalents, and Short-term Investments USD 299.38M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001759138-26-000047
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations USD 299.38M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001759138-26-000047
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect USD -22.63M 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-14 0000950170-24-126733
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD 216.40M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001759138-26-000047
us-gaap ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 Class of Warrant or Right, Exercise Price of Warrants or Rights USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-05 0001759138-26-000047
us-gaap ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights Class of Warrant or Right, Number of Securities Called by Warrants or Rights shares 3.09M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001759138-26-000047
us-gaap ClassOfWarrantOrRightOutstanding Class of Warrant or Right, Outstanding shares 53.09M 2025-12-31 2025 FY 10-K 2026-03-23 0001759138-26-000011
us-gaap CommonStockDividendsPerShareDeclared Common Stock, Dividends, Per Share, Declared USD/shares 0 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-30 0001564590-20-013929
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0 2019-10-16 2020 FY 10-K 2021-03-16 0001564590-21-013329
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 600.00M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001759138-26-000047
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 100.48M 2025-12-31 2025 FY 10-K 2026-03-23 0001759138-26-000011
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 100.48M 2025-12-31 2025 FY 10-K 2026-03-23 0001759138-26-000011
us-gaap CommonStockValue Common Stock, Value, Issued USD 2,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001759138-26-000047
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD -147.61M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001759138-26-000047
us-gaap ConversionOfStockAmountConverted1 Conversion of Stock, Amount Converted USD 97.95M 2019-01-01 2019-12-31 2020 FY 10-K 2021-03-16 0001564590-21-013329
us-gaap DebtConversionConvertedInstrumentAmount1 Debt Conversion, Converted Instrument, Amount USD 18.78M 2018-01-01 2018-12-31 2019 FY 10-K 2020-03-30 0001564590-20-013929
us-gaap DebtSecuritiesAvailableForSaleUnrealizedGainLoss Debt Securities, Available-for-sale, Unrealized Gain (Loss) USD -25,000 2026-01-01 2026-03-31 2026 Q3 10-Q 2026-11-05 0001759138-26-000047
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 163.04M 2025-12-31 2025 FY 10-K 2026-03-23 0001759138-26-000011
us-gaap DeferredTaxAssetsLiabilitiesNet Deferred Tax Assets, Net USD 0 2025-12-31 2025 FY 10-K 2026-03-23 0001759138-26-000011
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 5.19M 2025-12-31 2025 FY 10-K 2026-03-23 0001759138-26-000011
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsDomestic Deferred Tax Assets, Operating Loss Carryforwards, Domestic USD 257.61M 2025-12-31 2025 FY 10-K 2026-03-23 0001759138-26-000011
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsForeign Deferred Tax Assets, Operating Loss Carryforwards, Foreign USD 319.89M 2025-12-31 2025 FY 10-K 2026-03-23 0001759138-26-000011
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration Deferred Tax Assets, Operating Loss Carryforwards, Not Subject to Expiration USD 319.64M 2025-12-31 2025 FY 10-K 2026-03-23 0001759138-26-000011
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal Deferred Tax Assets, Operating Loss Carryforwards, State and Local USD 83.01M 2025-12-31 2025 FY 10-K 2026-03-23 0001759138-26-000011
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration Deferred Tax Assets, Operating Loss Carryforwards, Subject to Expiration USD 250,000 2025-12-31 2025 FY 10-K 2026-03-23 0001759138-26-000011
us-gaap DeferredTaxAssetsTaxCreditCarryforwardsResearch Deferred Tax Assets, Tax Credit Carryforwards, Research USD 25.05M 2025-12-31 2025 FY 10-K 2026-03-23 0001759138-26-000011
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost USD 13.30M 2025-12-31 2025 FY 10-K 2026-03-23 0001759138-26-000011
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities USD 2.81M 2025-12-31 2025 FY 10-K 2026-03-23 0001759138-26-000011
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 157.85M 2025-12-31 2025 FY 10-K 2026-03-23 0001759138-26-000011
us-gaap DefinedContributionPlanCostRecognized Defined Contribution Plan, Cost USD 1.06M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-23 0001759138-26-000011
us-gaap DefinedContributionPlanEmployerMatchingContributionPercent Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay pure 0.03 2019-01-01 2019-12-31 2021 FY 10-K 2022-03-17 0001564590-22-010726
us-gaap DefinedContributionPlanEmployerMatchingContributionPercentOfMatch Defined Contribution Plan, Employer Matching Contribution, Percent of Match pure 0.04 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-23 0001759138-26-000011
us-gaap DepositsAssetsNoncurrent Deposits Assets, Noncurrent USD 91,000 2019-09-30 2019 Q3 10-Q 2019-12-05 0001564590-19-045375
us-gaap Depreciation Depreciation USD 1.05M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001759138-26-000047
us-gaap Dividends Dividends USD 5.33M 2019-01-01 2019-12-31 2020 FY 10-K 2021-03-16 0001564590-21-013329
us-gaap DueToRelatedPartiesCurrentAndNoncurrent Due to Related Parties USD 13,000 2020-12-31 2020 FY 10-K 2021-03-16 0001564590-21-013329
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -0.98 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001759138-26-000047
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares -0.45 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-12 0001564590-22-019677
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -0.98 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001759138-26-000047
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-23 0001759138-26-000011
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-23 0001759138-26-000011
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure -0.329 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-31 0000950170-25-047201
us-gaap EffectiveIncomeTaxRateReconciliationCrossBorderTaxEffectAmount EffectiveIncomeTaxRateReconciliationCrossBorderTaxEffectAmount USD 94,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-23 0001759138-26-000011
us-gaap EffectiveIncomeTaxRateReconciliationCrossBorderTaxEffectPercent EffectiveIncomeTaxRateReconciliationCrossBorderTaxEffectPercent pure -0.001 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-23 0001759138-26-000011
us-gaap EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-23 0001759138-26-000011
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpense Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent pure 0.033 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-30 0001564590-20-013929
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent pure -0.006 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-23 0001759138-26-000011
us-gaap EffectiveIncomeTaxRateReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-23 0001759138-26-000011
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-23 0001759138-26-000011
us-gaap EffectiveIncomeTaxRateReconciliationTaxContingenciesDomestic Effective Income Tax Rate Reconciliation, Tax Contingency, Domestic, Percent pure -0.259 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-23 0001759138-26-000011
us-gaap EffectiveIncomeTaxRateReconciliationTaxCredits Effective Income Tax Rate Reconciliation, Tax Credit, Percent pure -0.056 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-23 0001759138-26-000011
us-gaap EffectiveIncomeTaxRateReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent pure -0.053 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-31 0000950170-25-047201
us-gaap EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD -38,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001759138-26-000047
us-gaap EmployeeRelatedLiabilitiesCurrent Employee-related Liabilities, Current USD 7.95M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001759138-26-000047
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount USD 31.67M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001759138-26-000047
us-gaap FairValueAssetsLevel1ToLevel2TransfersAmount Fair Value, Assets, Level 1 to Level 2 Transfers, Amount USD 0 2021-09-30 2021 Q3 10-Q 2021-11-01 0001564590-21-053043
us-gaap FairValueAssetsLevel2ToLevel1TransfersAmount Fair Value, Assets, Level 2 to Level 1 Transfers, Amount USD 0 2021-09-30 2021 Q3 10-Q 2021-11-01 0001564590-21-053043
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net USD 0 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-01 0001564590-21-053043
us-gaap FinanceLeaseInterestExpense Finance Lease, Interest Expense USD 2.00M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-23 0001759138-26-000011
us-gaap FinanceLeaseLiabilityCurrent Finance Lease, Liability, Current USD 13.68M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001759138-26-000047
us-gaap FinanceLeaseLiabilityNoncurrent Finance Lease, Liability, Noncurrent USD 4.74M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001759138-26-000047
us-gaap FinanceLeaseLiabilityPaymentsDue Finance Lease, Liability, Payment, Due USD 18.42M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001759138-26-000047
us-gaap FinanceLeaseLiabilityPaymentsDueInNextRollingTwelveMonths Finance Lease, Liability, Payments, Due in Next Rolling Twelve Months USD 21.91M 2025-12-31 2025 FY 10-K 2026-03-23 0001759138-26-000011
us-gaap FinanceLeaseLiabilityPaymentsDueInRollingYearTwo Finance Lease, Liability, Payments, Due in Rolling Year Two USD 3.28M 2025-12-31 2025 FY 10-K 2026-03-23 0001759138-26-000011
us-gaap FinanceLeaseLiabilityPaymentsDueNextTwelveMonths Finance Lease, Liability, to be Paid, Year One USD 15.50M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001759138-26-000047
us-gaap FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear Finance Lease, Liability, to be Paid, Remainder of Fiscal Year USD 4.37M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001759138-26-000047
us-gaap FinanceLeaseLiabilityUndiscountedExcessAmount Finance Lease, Liability, Undiscounted Excess Amount USD 1.45M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001759138-26-000047
us-gaap FinanceLeasePrincipalPayments Finance Lease, Principal Payments USD 11.02M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001759138-26-000047
us-gaap FinanceLeaseRightOfUseAsset Finance Lease, Right-of-Use Asset, after Accumulated Amortization USD 12.36M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001759138-26-000047
us-gaap FinanceLeaseRightOfUseAssetAmortization Finance Lease, Right-of-Use Asset, Amortization USD 3.10M 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-31 0000950170-25-047201
us-gaap FinanceLeaseWeightedAverageDiscountRatePercent Finance Lease, Weighted Average Discount Rate, Percent pure 0.1 2026-09-30 2026 Q3 10-Q 2026-11-05 0001759138-26-000047
us-gaap ForeignCurrencyTransactionLossBeforeTax Foreign Currency Transaction Loss, before Tax USD 81,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001759138-26-000047
us-gaap GainLossOnTerminationOfLease Gain (Loss) on Termination of Lease USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-21 0000950170-24-034422
us-gaap GainLossRelatedToLitigationSettlement Gain (Loss) Related to Litigation Settlement USD 0 2022-01-01 2022-06-30 2022 Q2 10-Q 2022-08-11 0000950170-22-016650
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 22.10M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001759138-26-000047
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001759138-26-000047
us-gaap IncomeTaxReconciliationForeignIncomeTaxRateDifferential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount USD 24,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-23 0001759138-26-000011
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD -35.30M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-23 0001759138-26-000011
us-gaap IncomeTaxReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount USD 983,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-23 0001759138-26-000011
us-gaap IncomeTaxReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Amount USD 203,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-23 0001759138-26-000011
us-gaap IncomeTaxReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-23 0001759138-26-000011
us-gaap IncomeTaxReconciliationTaxContingenciesDomestic Effective Income Tax Rate Reconciliation, Tax Contingency, Domestic, Amount USD 43.49M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-23 0001759138-26-000011
us-gaap IncomeTaxReconciliationTaxCredits Effective Income Tax Rate Reconciliation, Tax Credit, Amount USD 9.49M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-23 0001759138-26-000011
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD 2.24M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001759138-26-000047
us-gaap IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities USD 452,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001759138-26-000047
us-gaap IncreaseDecreaseInDeferredCharges Increase (Decrease) in Deferred Charges USD 817,000 2019-01-01 2019-06-30 2020 Q2 10-Q 2020-08-06 0001564590-20-037278
us-gaap IncreaseDecreaseInInterestPayableNet Increase (Decrease) in Interest Payable, Net USD -381,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001759138-26-000047
us-gaap IncreaseDecreaseInOperatingLeaseLiability IncreaseDecreaseInOperatingLeaseLiability USD -3.23M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001759138-26-000047
us-gaap IncreaseDecreaseInOtherOperatingAssets Increase (Decrease) in Other Operating Assets USD 3.41M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001759138-26-000047
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD 5.19M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001759138-26-000047
us-gaap InterestExpense Interest Expense USD 1.66M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001759138-26-000047
us-gaap InterestPaidNet Interest Paid, Excluding Capitalized Interest, Operating Activities USD 2.05M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001759138-26-000047
us-gaap InvestmentIncomeInterest Investment Income, Interest USD 4.82M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001759138-26-000047
us-gaap LeaseCost Lease, Cost USD 4.42M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-23 0001759138-26-000011
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 4.75M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001759138-26-000047
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Four USD 158,000 2019-09-30 2019 Q3 10-Q 2019-12-05 0001564590-19-045375
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Three USD 1.15M 2022-09-30 2022 Q3 10-Q 2022-11-10 0000950170-22-024168
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Two USD 0 2025-12-31 2025 FY 10-K 2026-03-23 0001759138-26-000011
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths Lessee, Operating Lease, Liability, Payments, Due Next Rolling Twelve Months USD 3.92M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001759138-26-000047
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 1.12M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001759138-26-000047
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 292,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001759138-26-000047
us-gaap Liabilities Liabilities USD 52.57M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001759138-26-000047
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 336.49M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001759138-26-000047
us-gaap LiabilitiesCurrent Liabilities, Current USD 47.33M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001759138-26-000047
us-gaap LongTermInvestments Long-term Investments USD 1.33M 2020-09-30 2020 Q3 10-Q 2020-11-10 0001564590-20-052757
us-gaap ManufacturingCosts Manufacturing Costs USD 29.64M 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-10 0001193125-25-273280
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 292.44M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001759138-26-000047
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD 50.82M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001759138-26-000047
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -126.82M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001759138-26-000047
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -147.59M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001759138-26-000047
us-gaap NetIncomeLossAvailableToCommonStockholdersBasic Net Income (Loss) Available to Common Stockholders, Basic USD -33.34M 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-16 0001564590-21-013329
us-gaap NoninterestExpenseOfferingCost Noninterest Expense Offering Cost USD 0 2024-01-01 2024-03-31 2024 Q1 10-Q 2024-05-15 0000950170-24-060045
us-gaap NumberOfOperatingSegments Number of Operating Segments Segment 1 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-23 0001759138-26-000011
us-gaap NumberOfReportingUnits Number of Reporting Units Segment 1 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-23 0001759138-26-000011
us-gaap OperatingExpenses Operating Expenses USD 151.02M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001759138-26-000047
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -151.02M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001759138-26-000047
us-gaap OperatingLeaseCost Operating Lease, Cost USD 4.21M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-23 0001759138-26-000011
us-gaap OperatingLeaseExpense Operating Lease, Expense USD 1.13M 2022-01-01 2022-09-30 2023 Q3 10-Q 2023-11-09 0000950170-23-061528
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 953,000 2023-10-01 2024 Q3 10-Q 2024-11-14 0000950170-24-126733
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 4.25M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001759138-26-000047
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 502,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001759138-26-000047
us-gaap OperatingLeasePayments Operating Lease, Payments USD 3.19M 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-14 0000950170-24-126733
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 4.71M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001759138-26-000047
us-gaap OperatingLeasesFutureMinimumPaymentsDue Operating Leases, Future Minimum Payments Due USD 5.02M 2023-12-31 2023 FY 10-K 2024-03-21 0000950170-24-034422
us-gaap OperatingLeasesFutureMinimumPaymentsDueCurrent Operating Leases, Future Minimum Payments Due, Next Twelve Months USD 2.28M 2022-12-31 2022 FY 10-K 2023-03-16 0000950170-23-008298
us-gaap OperatingLeasesFutureMinimumPaymentsDueInRollingYearThree Operating Leases, Future Minimum Payments, Due in Rolling Year Three USD 1.15M 2022-12-31 2022 FY 10-K 2023-03-16 0000950170-23-008298
us-gaap OperatingLeasesFutureMinimumPaymentsDueInRollingYearTwo Operating Leases, Future Minimum Payments, Due in Rolling Year Two USD 1.64M 2023-12-31 2023 FY 10-K 2024-03-21 0000950170-24-034422
us-gaap OperatingLeasesFutureMinimumPaymentsNextRollingTwelveMonths Operating Leases, Future Minimum Payments, Next Rolling Twelve Months USD 3.75M 2023-12-31 2023 FY 10-K 2024-03-21 0000950170-24-034422
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0.1 2026-09-30 2026 Q3 10-Q 2026-11-05 0001759138-26-000047
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 8.57M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001759138-26-000047
us-gaap OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax USD -25,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001759138-26-000047
us-gaap OtherLiabilitiesCurrent Other Liabilities, Current USD 70,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001759138-26-000047
us-gaap OtherOperatingIncomeExpenseNet Other Operating Income (Expense), Net USD 278,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001759138-26-000047
us-gaap OtherResearchAndDevelopmentExpense Other Research and Development Expense USD 2.73M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001759138-26-000047
us-gaap PaymentsForCommissions Payments for Commissions USD 1.11M 2025-04-01 2025-06-30 2025 Q2 10-Q 2025-08-07 0000950170-25-104573
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 147,000 2024-01-01 2024-03-31 2025 Q1 10-Q 2025-05-15 0000950170-25-071971
us-gaap PaymentsToAcquireAvailableForSaleSecuritiesDebt Payments to Acquire Debt Securities, Available-for-sale USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001759138-26-000047
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 142,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001759138-26-000047
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-05 0001759138-26-000047
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 10.00M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001759138-26-000047
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2026-09-30 2026 Q3 10-Q 2026-11-05 0001759138-26-000047
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2026-09-30 2026 Q3 10-Q 2026-11-05 0001759138-26-000047
us-gaap PreferredStockValue Preferred Stock, Value, Issued USD 0 2026-09-30 2026 Q3 10-Q 2026-11-05 0001759138-26-000047
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 10.46M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001759138-26-000047
us-gaap ProceedsFromConvertibleDebt Proceeds from Convertible Debt USD 12.54M 2018-01-01 2018-12-31 2019 FY 10-K 2020-03-30 0001564590-20-013929
us-gaap ProceedsFromIssuanceInitialPublicOffering Proceeds from Issuance Initial Public Offering USD 71.03M 2019-01-01 2019-09-30 2019 Q3 10-Q 2019-12-05 0001564590-19-045375
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 128.22M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001759138-26-000047
us-gaap ProceedsFromIssuanceOfConvertiblePreferredStock Proceeds from Issuance of Convertible Preferred Stock USD 50.00M 2019-01-01 2019-12-31 2020 FY 10-K 2021-03-16 0001564590-21-013329
us-gaap ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans Proceeds, Issuance of Shares, Share-based Payment Arrangement, Excluding Option Exercised USD 160,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001759138-26-000047
us-gaap ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale USD 50.96M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001759138-26-000047
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 167,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001759138-26-000047
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD -147.59M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001759138-26-000047
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 9.07M 2025-12-31 2025 FY 10-K 2026-03-23 0001759138-26-000011
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 1.01M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001759138-26-000047
us-gaap ReclassificationsOfTemporaryToPermanentEquity Reclassifications of Temporary to Permanent Equity USD -5.33M 2019-01-01 2019-12-31 2020 FY 10-K 2021-03-16 0001564590-21-013329
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 128.93M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001759138-26-000047
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -664.54M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001759138-26-000047
us-gaap RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability Right-of-Use Asset Obtained in Exchange for Finance Lease Liability USD 4.21M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001759138-26-000047
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 7.27M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001759138-26-000047
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 16.02M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001759138-26-000047
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001759138-26-000047
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate pure 1.16 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-14 0001759138-26-000026
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum pure 1.18 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-23 0001759138-26-000011
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum pure 1.12 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-23 0001759138-26-000011
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum pure 0.051 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001759138-26-000047
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum pure 0.037 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001759138-26-000047
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period shares 108,949 2024-01-01 2024-06-30 2024 Q2 10-Q 2024-08-08 0000950170-24-093325
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 2.74 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001759138-26-000047
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price USD/shares 14.96 2024-01-01 2024-06-30 2024 Q2 10-Q 2024-08-08 0000950170-24-093325
us-gaap ShortTermInvestments Short-term Investments USD 0 2026-09-30 2026 Q3 10-Q 2026-11-05 0001759138-26-000047
us-gaap ShortTermLeaseCost Short-term Lease, Cost USD 34,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-23 0001759138-26-000011
us-gaap StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants Stock and Warrants Issued During Period, Value, Preferred Stock and Warrants USD 32.56M 2022-01-01 2022-12-31 2023 FY 10-K 2024-03-21 0000950170-24-034422
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 283.92M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001759138-26-000047
us-gaap StockholdersEquityNoteStockSplitConversionRatio1 Stockholders' Equity Note, Stock Split, Conversion Ratio pure 0.67 2019-10-15 2019-10-16 2020 FY 10-K 2021-03-16 0001564590-21-013329
us-gaap StockIssuedDuringPeriodValueConversionOfUnits Stock Issued During Period, Value, Conversion of Units USD 97.95M 2019-01-01 2019-12-31 2020 FY 10-K 2021-03-16 0001564590-21-013329
us-gaap StockIssuedDuringPeriodValueEmployeeStockPurchasePlan Stock Issued During Period, Value, Employee Stock Purchase Plan USD 160,000 2026-04-01 2026-06-30 2026 Q3 10-Q 2026-11-05 0001759138-26-000047
us-gaap StockIssuedDuringPeriodValueIssuedForServices Stock Issued During Period, Value, Issued for Services USD 1.16M 2018-01-01 2018-12-31 2019 FY 10-K 2020-03-30 0001564590-20-013929
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 140.20M 2026-04-01 2026-06-30 2026 Q3 10-Q 2026-11-05 0001759138-26-000047
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 101,000 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001759138-26-000047
us-gaap TemporaryEquityCarryingAmountAttributableToParent Temporary Equity, Carrying Amount, Attributable to Parent USD 43.92M 2018-12-31 2019 FY 10-K 2020-03-30 0001564590-20-013929
us-gaap TemporaryEquityLiquidationPreference Temporary Equity, Liquidation Preference USD 94.47M 2019-09-30 2019 Q3 10-Q 2019-12-05 0001564590-19-045375
us-gaap TemporaryEquitySharesAuthorized Temporary Equity, Shares Authorized shares 20.76M 2019-01-31 2020 FY 10-K 2021-03-16 0001564590-21-013329
us-gaap TemporaryEquitySharesIssued Temporary Equity, Shares Issued shares 0 2018-09-30 2019 Q3 10-Q 2019-12-05 0001564590-19-045375
us-gaap TemporaryEquitySharesOutstanding Temporary Equity, Shares Outstanding shares 19.36M 2019-09-30 2019 Q3 10-Q 2019-12-05 0001564590-19-045375
us-gaap TemporaryEquityStockIssuedDuringPeriodValueNewIssues Temporary Equity, Stock Issued During Period, Value, New Issues USD 50.00M 2019-01-01 2019-09-30 2019 Q3 10-Q 2019-12-05 0001564590-19-045375
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 0 2026-09-30 2026 Q3 10-Q 2026-11-05 0001759138-26-000047
us-gaap UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued USD 0 2025-12-31 2025 FY 10-K 2026-03-23 0001759138-26-000011
us-gaap UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate Unrecognized Tax Benefits that Would Impact Effective Tax Rate USD 0 2025-12-31 2025 FY 10-K 2026-03-23 0001759138-26-000011
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD 47.13M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-23 0001759138-26-000011
us-gaap VariableLeaseCost Variable Lease, Cost USD 171,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-23 0001759138-26-000011
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 150.26M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001759138-26-000047
us-gaap WeightedAverageNumberOfShareOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted shares 1.81M 2019-01-01 2019-09-30 2020 Q3 10-Q 2020-11-10 0001564590-20-052757
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 150.26M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001759138-26-000047

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →